Using intravenous iron to treat anemia after heart surgery
Official title: Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac Surgery: A Pilot, Multi-centre, Placebo-controlled Randomized Trial.
Run by University Health Network, Toronto · NCT06287619 · Data updated 2026-11-12
This study is testing if giving intravenous iron to patients with anemia after heart surgery can help them stay out of the hospital and feel better.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University Health Network, Toronto Academic / other |
| Locations | 3 sites (Kingston, Ontario and 2 other locations) |
| Status | Recruiting |
| Started | April 3, 2025 |
| Main results expected | December 2026 |
| Study ends | June 2027 |
| Registry record updated | February 10, 2026 |
| Trial ID | NCT06287619 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old with preoperative iron-deficiency anemia scheduled for non-emergency cardiac surgery involving cardiopulmonary bypass.
✕Probably not a fit
Patients with contraindications to intravenous iron or those undergoing specialized cardiac procedures may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, randomized, controlled pilot trial aims to evaluate the feasibility of a larger study investigating the effects of intravenous iron therapy on patients with chronic iron-deficiency anemia undergoing cardiac surgery. Participants will receive either the iron treatment or a placebo shortly after surgery, with a follow-up dose at 42 days if necessary. The primary outcome measure will be the number of days alive and out of the hospital within 90 days post-surgery. The trial is being conducted at three cardiac surgery centers in Canada.
Why it matters
Potential benefit: If successful, this approach could significantly improve recovery outcomes for patients with anemia undergoing cardiac surgery.
How similar studies have gone: Previous studies have shown promising results with intravenous iron therapy in similar patient populations, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients who are undergoing any non-emergency open cardiac surgery and who meet all following criteria: 1. Age greater than 18 years old 2. Preoperative iron-deficiency with or without anemia (defined as Hb \<130 g/L) with any one of: 1. ferritin ≤100 μg/l; or 2. ferritin ≤ 300 μg/L and transferrin saturation ≤ 20%; or 3. reticulocyte Hb content \< 29 pg, where available Exclusion Criteria: Patients who meet any of the following criteria are not eligible for the study: 1. specialized procedures (e.g., ventricular assist device insertion, thoracoabdominal aneurysm, complex adult congenital surgery and heart transplant) 2. established contraindications to IV iron: 1. hypersensitivity to the iron product 2. history of \>2 food and/or drug allergic reactions (excluding drug intolerance) 3. non-iron deficiency anemias such as myelodysplastic syndrome 4. history of iron overload or disturbances in use of iron such as hemochromatosis or hemosiderosis 5. decompensated liver cirrhosis (MELD ≥ 19) or active hepatitis 6. active infection 3. preoperative unstable hemodynamics defined as the requirement for vasopressors or inotropes, or active bleeding (as noted in the clinical record and/or defined as a requirement for red blood cell transfusion for ongoing clinical bleeding) 4. refusal of blood products for religious or other reasons 5. known pregnancy 6. already enrolled in this trial 7. enrolment in another interventional trial which may impact anemia or transfusion management (for example, a trial of hemostatic therapies, such as tranexamic acid) 8. receipt of intravenous iron at any point in the 6 weeks prior to randomization
Where it's running
-
Kingston Health Sciences Centre
Kingston, Ontario, Canada Recruiting -
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada Recruiting -
Toronto General Hospital - University Health Network
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Justyna Bartoszko, MD — University Health Network, Toronto
- Study coordinator: Keyvan Karkouti, MD
- Email: Keyvan.Karkouti@uhn.ca
- Phone: 416-340-4800
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Impact of Fast-Track Anesthesia on Postoperative Delirium After Cardiac Surgery
This observational study tests whether fast-track anesthesia, compared with conventional care, is linked to lower rates of delirium after elective cardiac surgery in adults.
-
Sarcopenia in Patients After Cardiac Surgery
This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.
-
Preoperative functional optimization for adults undergoing major cardiac or abdominal surgery
This study tests a four‑week prehabilitation program to improve fitness before elective major cardiac or abdominal surgery.
-
Oral Extubation Right After Cardiac Surgery
This trial tests whether waking patients and removing the breathing tube in the operating room after elective cardiac surgery helps recovery more quickly without added risk.
-
Frailty and Ultrasound-Guided Catheterization in Adult Cardiac Surgery Patients
This study tests whether frailty and ultrasound measurements taken before surgery can predict how difficult it will be to place an ultrasound-guided internal jugular venous catheter in adults undergoing elective cardiac surgery.
-
Prehabilitation before heart surgery for adults with congenital heart disease
This study is testing whether a tailored, supervised exercise program before heart surgery helps adults with congenital heart disease perform better and improve fitness.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.